Table 4 |
|||||||
|
miRNAs differentially expressed in treatment with GH responders vs. GH noresponders |
|||||||
|
Up regulated |
Down regulated |
||||||
|
|
|
||||||
|
Name |
Fold |
P value |
FDR |
Name |
Fold |
P value |
FDR |
|
|
|||||||
|
miR-125b |
2.73 |
0.034 |
0.013 |
miR-125a-5p |
0.42 |
0.043 |
0.029 |
|
miR-886-5p |
12.41 |
0.015 |
0.025 |
miR-198 |
0.46 |
0.012 |
0.005 |
|
miR-503 |
0.31 |
0.031 |
0.077 |
||||
|
miR-524-5p |
0.41 |
0.036 |
0.033 |
||||
|
miR-630 |
0.42 |
0.022 |
0.095 |
||||
|
|
|||||||
|
Note: The threshold value used to screen up- and down-regulated miRNAs was fold change >2.00 or fold change <0.50. |
|||||||
|
Mao et al. Diagnostic Pathology 2010 5:79 doi:10.1186/1746-1596-5-79 |
|||||||
